Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0684
D

Failure to Follow Insulin and Blood Glucose Monitoring Orders

Zanesville, Ohio Survey Completed on 05-01-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to follow physician orders for insulin administration and blood glucose monitoring for a resident with type 2 diabetes and a history of atherosclerotic heart disease and coronary bypass graft. The resident had orders for Lantus insulin once daily, Insulin Lispro before meals and as needed per sliding scale, and blood glucose monitoring, including the use of a Freestyle Libre sensor. After returning from an endocrinology appointment, the resident's orders were updated to continue insulin and initiate the glucose monitoring device. However, Insulin Lispro was discontinued, and blood glucose monitoring was not performed as ordered. Review of the medication administration records showed that the resident stopped receiving Insulin Lispro and did not have blood glucose checks from the time the new orders were received until the time of the survey, except during blood draws. The resident reported that staff had not been monitoring her blood sugars and that her glucose monitoring device had come off, requiring a two-week wait for replacement. Interviews with facility staff and the endocrinologist's office confirmed that the orders were not clarified or followed, resulting in a lack of appropriate blood glucose monitoring and insulin administration.

An unhandled error has occurred. Reload 🗙